Vir Biotechnology, Inc. - stock earnings

VIR Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
May 2, 2024 AfterMarket -0.48 / -1.06 - 56.4 million / 11.8 million -

VIR Quarterly earnings

DateEarningsRevenue
2024Q1 -65.3 million USD 56.4 million USD
2023Q4 -116.0 million USD 16.8 million USD
2023Q3 -163.4 million USD -4.1 million USD
2023Q2 -194.8 million USD -12.7 million USD
2023Q1 -141.0 million USD 46.7 million USD
2022Q4 -101.6 million USD 21.8 million USD
2022Q3 175.3 million USD 371.4 million USD
2022Q2 -76.5 million USD -42.7 million USD
2022Q1 518.6 million USD 1.2 billion USD
2021Q4 525.3 million USD 809.8 million USD
2021Q3 110.4 million USD 102.7 million USD
2021Q2 61.8 million USD 174.0 million USD
2021Q1 -168.9 million USD 605000 USD
2020Q4 -105.6 million USD 301000 USD
2020Q3 -84.6 million USD 188000 USD
2020Q2 -31.2 million USD 66.3 million USD
2020Q1 -77.2 million USD 487000 USD
2019Q4 -63.8 million USD 371000 USD
2019Q3 -48.3 million USD 237000 USD
2019Q2 -33.9 million USD 86000 USD
2019Q1 -28.7 million USD 17000 USD
2018Q4 -26.4 million USD 6000 USD
2018Q3 -33.5 million USD 114000 USD
2018Q2 -56.0 million USD 4.7 million USD
2018Q1 -28.0 million USD 2.3 million USD

VIR Yearly earnings

DateEarningsRevenue
2023 -615.1 million USD 86.2 million USD
2022 515.8 million USD 1.6 billion USD
2021 528.6 million USD 1.1 billion USD
2020 -298.7 million USD 76.4 million USD
2019 -174.7 million USD 711000 USD
2018 -115.9 million USD 868000 USD
2017 -69.9 million USD 149000 USD

VIR

Price: $10.39

52 week price:
7.61
27.48

Earnings Per Share: -4.59 USD

P/E Ratio: -1.91

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 703157

Market Capitalization: 1.4 billion

Links: